Clinical Research Directory
Browse clinical research sites, groups, and studies.
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Sponsor: International Peace Maternity and Child Health Hospital
Summary
It is intended to examine the efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.
Official title: The Efficacy of Intravenous Immunoglobulin for the Treatment of Bronchopulmonary Dysplasia
Key Details
Gender
All
Age Range
Any - 10 Weeks
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-04-12
Completion Date
2027-12
Last Updated
2026-04-01
Healthy Volunteers
Yes
Conditions
Interventions
intravenous immunoglobulin
1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.
Locations (1)
International Peace Maternity and Child Health Hospital
Shanghai, Shanghai Municipality, China